News & Events
Displaying 33 - 42 of 42
Displaying 33 - 42 of 42
Tobias Deuse, MD and Sonja Schrepfer, MD, PhD Lead Research Team Unearthing New Clues to Stem Cell Transplant Rejection
UCSF News
August 20, 2019
Mutations in Mitochondrial DNA Induced by Cell Reprogramming May Trigger Immune Response In 2006, scientists discovered a way to “reprogram” mature cells – adult skin cells, for example – into stem cells that could, in principle, give rise to any tissue or organ in the body. Many assumed it was only a matter of...
UCSF Health
August 15, 2019
Tobias Deuse, MD, Professor of Surgery at UCSF, and a cardiac and heart transplant surgeon internationally renowned for his pioneering work in the development of minimally-invasive techniques for mitral valve repair, discusses the advantages of minimally invasive approaches for the treatment of mitral valve...
Gavitt A. Woodard, MD, Awarded Intuitive Surgical Robotics Fellowship from AATS Foundation
UCSF Cardiothoracic Surgery
May 08, 2019
Gavitt A. Woodard, M.D., a cardiothoracic surgery fellow at UCSF, has been awarded an Intuitive Surgical Robotics Fellowship from the American Association of Thoracic Surgeons (AATS) Foundation. This opportunity provides advanced robotic training and certification to a select group of fellows each year. Dr...
CRISPR Gene Editing Makes Stem Cells ‘Invisible’ to Immune System
Transplant and Stem Cell Immunobiology (TSI) Lab
February 26, 2019
Technique Prevents Transplant Rejection in the Lab, a Major Advance for Stem Cell Therapies Human heart muscle cells derived from triple-engineered stem cells that are “invisible” to the immune system. The red is troponin, a protein that participates in cardiac muscle contraction. The blue is the cell’s nucleus...
Johannes Kratz Named Van Auken Endowed Chair in Thoracic Oncology
UCSF Department of Surgery
February 24, 2018
Johannes R. Kratz, M.D. has been named the new Van Auken Endowed Chair in Thoracic Oncology. Kratz is an assistant professor in the Division of Adult Cardiothoracic Surgery, a member of the Thoracic Oncology Program, and director of Advanced Minimally Invasive Thoracic Surgery. The Van Auken Endowed Chair supports...
Tobias Deuse, M.D., Named The Julien I. E. Hoffman, M.D. Chair in Cardiac Surgery
UCSF Cardiothoracic Surgery
January 26, 2018
Tobias Deuse, M.D., associate professor of surgery and director of minimally-invasive cardiac surgery at UCSF, has been named The Julien I. E. Hoffman, M.D. Chair in Cardiac Surgery. Dr. Deuse, a cardiac and heart transplant surgeon, is internationally renowned for his pioneering work in the development of...
Johannes Kratz and Yeranuí Ledesma Recipients of UCSF Health Exceptional Physician Awards
UCSF Department of Surgery
July 27, 2017
Johannes R. Kratz, M.D. and Yeranuí Ledesma, M.D. are among this year's recipients of the 2017 UCSF Health Exceptional Physician Award. Dr. Kratz, now a member of the Thoracic Oncology Program and Assistant Professor in the Division of Adult Cardiothoracic Surgery, and Dr. Ledesma, a Senior Resident in General...
Study Suggests Prognostic Molecular Assay More Accurate than Conventional NCCN Criteria in Stratifying Risk in Early-Stage NSCLC Patients
UCSF Thoracic Oncology Program
November 07, 2014
Building on earlier retrospective validation studies , a team of Thoracic Oncology Program researchers, demonstrated in a small prospective study the clinical utility of a 14-gene expression assay in stratifying risk among non-small cell lung cancer (NSCLC) patients. In a recently published paper in the journal...
Julius Guccione "Mesmerized" by Virtual 3D Image of Beating Heart
Cardiac Biomechanics Lab
January 16, 2014
Dr. Julius Guccione, a biomedical engineer and co-director of the UCSF Cardiac Biomechanics Lab, lauded the development of technology rendering a virtual image of a beating heart by Dassault Systèmes, a French design and simulation software company. Dassault has developed a complete, three-dimensional view of the...
Molecular Test Identifies Early-Stage Lung Cancer Patients at High Risk of Death After Surgery
UCSF Thoracic Oncology Program
November 01, 2012
Building on their earlier work reported in The Lancet, UCSF thoracic surgeon Michael Mann, M.D. (left), and Johannes Kratz, M.D. (right) a former surgical resident in the Thoracic Oncology Lab, showed they could accurately stratify patients even with the earliest stage of lung cancer into groups at low-...